 Ohm Laboratories to Market in OTC Private Label Market. 
 
 Ranbaxy Laboratories Limited (RLL) announced today that the Company has received final approval from the U.

<tr><td><p class='TableClas'></p><P class='TableClas'><DIV CLASS=rightDiv><script language="JavaScript">
		google_ad_client = 'businessstandard';
		//google_ad_client = 'ca-businessstandard_js';
		google_ad_width = 200;
		google_ad_height = 200;
		google_ad_format = "200x200_as";
		google_ad_type = "text";
		google_ad_channel = "";
		//google_color_border = "FFFFFF";
		google_color_border = "F7F7F7";
		//google_color_bg = "FFFFFF";
		google_color_bg = "ffffff";
		//google_color_link = "639ACE";
		google_color_link = "0253B7";
		google_color_text = "000000";
		google_color_url = "D63431";
		//google_skip = adsenseSkip;
		</script> 
		<script type="text/javascript" src="http://pagead2.googlesyndication.com/pagead/show_ads.js">
		</script> </DIV><p class='TableClas'>
</p><p class='TableClas'>Ranbaxy Laboratories Limited (RLL) announced today that the Company has received final approval from the U.S. Food and Drug Administration to manufacture and market Cetirizine Hydrochloride Oral Solution (Allergy) and Children

Ranbaxy receives final US FDA approval

Also Read

PS Saminthan to head Pyramid Saimira Group

Srishti Software successfully implements PACS

GSK inaugurates development centre in India

Jet launched daily flights to Abu Dhabi

Polaris income grows to Rs. 1,117 crore

Explore News